Carbohydrate antigen19-9 (CA19-9) levels in patients with autosomal dominant polycystic kidney disease (ADPKD)

Carbohydrate antigen19-9 (CA19-9) levels in patients with autosomal dominant polycystic kidney disease (ADPKD) - CA19-9 levels in ADPKD

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000021735

Enrollment

200

Registered

2016-04-01

Start date

2014-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

autosomal dominant polycystic kidney disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with ADPKD

Exclusion criteria

Exclusion criteria: under 18 y.o. and more than 90 y.o.

Design outcomes

Primary

Measure	Time frame
The serum CA19-9 levels	—

Countries

Japan

Contacts

Public ContactHirotaka Fukasawa

Iwata City Hospital Renal Division

hfukasawaucsd@gmail.com0538-38-5000

Outcome results